Latest Content

Choosing the Appropriate Treatment for Metastatic Uveal Melanoma

August 23rd 2024, 3:59pm

By Nathan L. Scott, M.D.

Video

Nathan L. Scott, M.D., provides a brief overview of the current guidelines for treatment of metastatic uveal melanoma, as well as what considerations go into choosing the appropriate treatment for it. This program was made possible with support from Immunocore.

Uveal Melanoma Prognosis and Risk Stratification

August 23rd 2024, 3:52pm

By Nathan L. Scott, M.D.

Video

Nathan L. Scott, M.D., discusses the risk of recurrence within diagnosed uveal melanoma patients. Uveal Melanoma Prognosis and Risk Stratification

Diagnosing Uveal Melanoma

August 23rd 2024, 3:44pm

By Nathan L. Scott, M.D.

Video

Nathan L. Scott, M.D., details what tests a patient should expect if they wish to confirm a uveal melanoma diagnosis. This program was made possible with support from Immunocore.

Resources for Patients With Newly Diagnosed Uveal Melanoma

August 23rd 2024, 3:44pm

By Nathan L. Scott, M.D.

Video

Melody Burchett discusses how she educates patients who have been recently diagnosed with uveal melanoma. Resources for Patients With Newly Diagnosed Uveal Melanoma

A Cure in Sight: Who We Are

August 23rd 2024, 3:41pm

By Nathan L. Scott, M.D.

Video

Melody Burchett discusses her journey with uveal melanoma and the formation of A Cure in Sight. This program was made possible with support from Immunocore.

Danielle Fishel of ‘Boy Meets World’ Has Cancer, ‘Emily in Paris’ Star Discusses Her Diagnosis and More

August 23rd 2024, 3:00pm

By Ashley Chan

Article

From Danielle Fishel and Rick Steves announcing their diagnosis to the “Emily in Paris” star discussing her cancer experience, here’s what’s happening in the oncology space this week.

Brief Overview of Uveal Melanoma

August 23rd 2024, 2:43pm

By Nathan L. Scott, M.D.

Video

After a brief introduction, Nathan L. Scott, M.D., gives an overview of uveal melanoma, including the risk factors and ways to help prevent it. This program was made possible with support from Immunocore.

What Patients With Kidney Cancer Need to Know About Welireg

August 23rd 2024, 1:00pm

By Alex Biese

Article

One expert explained why ‘it’s very important to know what’s going on’ with regard to new renal cell carcinoma treatments.

ARPIs May Improve Survival in Some With Prostate Cancer

August 22nd 2024, 9:00pm

By Ashley Chan

Article

Androgen receptor pathway inhibitors were shown to better treat patients with metastatic castration-resistant prostate cancer and improved survival.

Immunotherapy/TKI Combo Has ‘Significant Burden of Toxicity’

August 22nd 2024, 7:00pm

By Brielle Benyon

Article

Researchers investigated the incidence of moderate to severe side effects for patients being treated with a combination of TKI and immunotherapy.

Balancing A Love of Cats With Lymphedema After Breast Cancer

August 22nd 2024, 5:00pm

By Felicia Mitchell

Article

If you have lymphedema after breast cancer and want to enjoy the company of cats, there are strategies to avoid potential problems, especially scratches.

Afinitor May Not Boost Outcomes in Non-Clear Cell Kidney Cancer

August 22nd 2024, 3:00pm

By Brielle Benyon

Article

Afinitor did not improve relapse-free survival in patients with non-clear cell renal cell carcinoma — a kidney cancer subtype linked to poor prognosis.

I Am in Here: A Poem About Life With Cancer

August 22nd 2024, 1:00pm

By Felicia S. Johnson

Article

Chemotherapy-related baldness pressured my strained self-identity. Was I the same person?

Ensuring Informed CML Care from Diagnosis Onward

August 21st 2024, 8:10pm

By Jorge E. Cortes, MD

Video

Experts on chronic myeloid leukemia delve into the important role of informed shared decision-making in the optimal treatment of patients with CML.

CML Treatment: Scenarios that Necessitate Switching Therapy

August 21st 2024, 8:03pm

By Jorge E. Cortes, MD

Video

Jorge E. Cortes, MD, details clinical scenarios that indicate a need to switch therapies for patients with chronic myeloid leukemia.